We observed that renal clear cell carcinomas with low NF-κB expression from different patho-clinical categories (gender, grade 3, low mutation status, low neoantigen rate) were significantly correlated with longer patient survival times than tumors with high NF-κB expression using Kaplan-Meier statistics. This evidence concerns the gene NFKB1 and clear cell renal carcinoma.